Unfrequent presentation of retinosis pigmentosa during pandemic times

Authors

Keywords:

retinitis pigmentosa, dystrophy, retina, nyctalopathy.

Abstract

Introduction: The pathology of retinitis pigmentosa comprises a wide range of manifestations that have as a common characteristic polygenetic inheritance (with at least 215 genes involved), dystrophy and the imminent progression of retinal material loss at the photoreceptor level, either from cones and/or rods, and the retinal pigment epithelium. It leads to blindness, although it is a curable or avoidable pathology, and an estimated global prevalence of 1 in 4,000.

Objective: To record the infrequent presentation of concomitant retinitis pigmentosa and unilateral sclerouveitis without associated family history for any previous pathology.

Case report: The case of a 45-year-old female patient is reported. The reason for consultation was secondary to red eye, pain with eye movements, together with a slow and progressive decrease in vision.

Result: The clinical evidence of the case and the high suspicion allow early and effective diagnosis.

Conclusions: In Latin American and the Third World countries, where the use of technological materials is expensive or beyond the reach of the patient's economy, it is necessary to resume clinical evidence to prevent rather than cure. Time is vision.

Downloads

Download data is not yet available.

Author Biography

Arturo Iván Pérez Pacheco, Hospital Star Mèdica, Queretaro, Mexico.

Investigador en Salud

References

Gawęcki M. Laser treatment in retinitis pigmentosa review. Laser Med Sci. 2020;35:1663-70. DOI: https://doi.org/10.1007/s10103-020-03036-9

Fahim A. Retinitis Pigmentosa. Current Opinion Pediatrics. 2018;30:725-33. DOI: https://doi.org/10.1097/MOP.0000000000000690

Stanca TH, Tabacaru B, Suvac E. Clinical particularities in an atypical case of retinitis pigmentosa. Roman J Ophthalmol. 2016 [acceso 20/08/2021];60(1):43-6. Disponible en: https://pubmed.ncbi.nlm.nih.gov/27220233/

Narasimha I, Murali A, Subramanian K, Ramalingam S, Parameswaran S. Autosomal dominant retinitis pigmentosa with toxic gain of function: Mechanisms and therapeutics. European J Opthalmol. 2020;31:304-20. DOI: https://doi.org/10.1177/1120672120957605.

Lang M, Harris A, Ciulla TA, Siesky B, Patel P, Belamkar A, et al. Vacular dysfunction in retinitis pigmentosa. Acta Opthalmology. 2019;97:660-4. DOI: https://doi.org/10.1111/aos.14138

WMA. Declaración de Helsinksi de la Asociación Médica Mundial. Principios éticos para las investigaciones en seres humanos. WMA. 2021 [acceso 23/11/2022]. Disponible en: https://www.wma.net/es/policies-post/declaracion-de-helsinki-de-la-amm-principios-eticos-para-las-investigaciones-medicas-en-seres-humanos/

García Dávila KJ, Vélez Muskus VJ, Narváez Rumié OM, Trujillo Güiza ML. Hallazgos clínicos en retinosis pigmentaria por examen visual, campimetría y retinografía en Colombia. Cienc Tecnol Salud Vis Ocul. 2020;18:55-64. DOI: https://doi.org/10.19052/sv.vol18.iss2.6

Lu Y, Sun X. Retinitis pigmentosa sine pigmento masqueraded as myopia. Medicine. 2021;100:24006. DOI: http://dx.doi.org/10.1097/MD.0000000000024006

Bruninx R, Lepièce G. L´image du mois. La rètinite pigmentaire (Retinitis pigmentosa). Rev Med Liege. 2020 [acceso 20/08/2021];75(2):73-4. Disponible en: https://pubmed.ncbi.nlm.nih.gov/32030928/

Published

2023-04-18

How to Cite

1.
Pérez Pacheco AI, Domínguez Mora A. Unfrequent presentation of retinosis pigmentosa during pandemic times. Acta Médica [Internet]. 2023 Apr. 18 [cited 2025 Mar. 14];24(1). Available from: https://revactamedica.sld.cu/index.php/act/article/view/353

Issue

Section

Presentación de caso